News Release

Aspirin use and incidence of colorectal cancer according to lifestyle risk

JAMA Oncology

Peer-Reviewed Publication

JAMA Network

About The Study: Aspirin use was associated with a greater absolute reduction in risk of colorectal cancer among individuals with less healthy lifestyles in this cohort study. The findings of the study suggest that lifestyle risk factors may be useful to identify individuals who may have a more favorable risk-benefit profile for cancer prevention with aspirin. 

Corresponding Authors: To contact the corresponding authors, email Andrew T. Chan, MD, MPH (achan@mgh.harvard.edu) and Long H. Nguyen, MD, MS (lnguyen24@mgh.harvard.edu).

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2024.2503)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.2503?guestAccessKey=272cd587-5b58-46d3-88ff-96c77577f1cc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080124


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.